Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): A long-term follow-up of the randomized, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network Meeting Abstract
| Authors: | Hermine, O.; Jiang, L.; Walewski, J.; Bosly, A.; Szymczyk, M.; Thieblemont, C.; Pott, C.; Salles, G.; Feugier, P.; Hübel, K.; Burroni, B.; Klapper, W.; Unterhalt, M.; Hoster, E.; Dreyling, M. |
| Abstract Title: | Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): A long-term follow-up of the randomized, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network |
| Meeting Title: | 63nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736398801156 |
| DOI: | 10.1182/blood-2021-150181 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 380 -- Hybrid meeting, also took place online -- Source: Wos |
